1.
Sci Transl Med
; 4(149): 149fs31, 2012 Aug 29.
Article
in English
| MEDLINE
| ID: mdl-22932219
ABSTRACT
The U.S. Food and Drug Administration applies regulatory flexibility to balance benefits and risks to subjects in cell-therapy clinical trials.